Charité Campus Mitte

Berlin 10117

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Chronic Cluster Headache, Cluster Headache, Episodic, Post-polio Syndrome, Primary Breast Cancer AR+ve TNBN, Primary Breast Cancer ER+ve, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome — Stopped early
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) — Completed
• Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer — Completed